In 2011, Ropharma posted a net profit of RON10.5 million.
The company forecasts total sales of RON431.5 million in 2012, from RON385.1 million a year earlier, according to its revenue and expenditure budget approved Monday.
Ropharma is indirectly owned by local businessman Mihai Miron. Cyprus-registered ADD Pharmaceuticals holds a 23.46% stake, while Rimia Investments holds 21.43%. Other shareholders include Arrow Pharmaceuticals with 31.31% and Romania’s privatization authority AVAS with 0.33%.
The company has a share capital of RON29.1 million, split into 291 million shares with a face value of RON0.1.
On the Bucharest bourse Friday, Ropharma closed down 2.74% at RON0.71 a share. (EUR1=RON4.3786)